Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tirzepatide for Obesity Treatment and Diabetes Prevention
Ania M. Jastreboff, Carel W. le Roux, Adam Stefański, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Integrated Management of Cardiovascular–Renal–Hepatic–Metabolic Syndrome: Expanding Roles of SGLT2is, GLP-1RAs, and GIP/GLP-1-RAs
Nikolaos Theodorakis, Maria Nikolaou
Biomedicines (2025) Vol. 13, Iss. 1, pp. 135-135
Open Access | Times Cited: 6
From Cardiovascular-Kidney-Metabolic Syndrome to Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Proposing an Expanded Framework
Nikolaos Theodorakis, Maria Nikolaou
Biomolecules (2025) Vol. 15, Iss. 2, pp. 213-213
Open Access | Times Cited: 4
Tackling suboptimal clinical response after metabolic bariatric surgery: Impact of tirzepatide on weight loss and body composition
Fabian Stoll, Tobias Kantowski, Jonas Laaser, et al.
Obesity Research & Clinical Practice (2025) Vol. 19, Iss. 1, pp. 63-69
Open Access | Times Cited: 1
Cardiovascular–Endocrine–Metabolic Medicine: Proposing a New Clinical Sub-Specialty Amid the Cardiometabolic Pandemic
Nikolaos Theodorakis, Maria Nikolaou, Andrew J. Krentz
Biomolecules (2025) Vol. 15, Iss. 3, pp. 373-373
Open Access | Times Cited: 1
Binding Kinetics, Bias, Receptor Internalization and Effects on Insulin Secretionin vitroandin vivoof a Novel GLP-1R/GIPR Dual Agonist, HISHS-2001
Yusman Manchanda, Ben Jones, Gaëlle Carrat, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Taxifolin as a Therapeutic Potential for Weight Loss: A Retrospective Longitudinal Study
Yorito Hattori, Yuriko Nakaoku, Soshiro Ogata, et al.
Nutrients (2025) Vol. 17, Iss. 4, pp. 706-706
Open Access
Tirzepatide - a promising medication for cardiovascular protection and treatment of Type 2 diabetes and obesity
Pavlína Piťhová
Vnitřní lékařství (2025) Vol. 71, Iss. 1, pp. 51-57
Closed Access
Adipositastherapie und Diabetesprävention mit Tirzepatid
Robin Schürfeld
Deleted Journal (2025)
Closed Access
November Industry News
Fiona McCartney
Therapeutic Delivery (2025), pp. 1-6
Closed Access
JCL ROUNDTABLE: PREDIABETES
Kevin C. Maki, Carol F. Kirkpatrick, Jaime P. Almandoz
Journal of clinical lipidology (2025)
Closed Access
Integrating social determinants of health into global approaches to early-onset type 2 diabetes
Jae‐Bin Seo, Manfredi Rizzo, Tiffany M. Powell‐Wiley
Journal of Diabetes and its Complications (2025) Vol. 39, Iss. 4, pp. 108982-108982
Closed Access
Real-World Use and Effectiveness of Tirzepatide Among People Without Evidence of Type 2 Diabetes in the United States
Emily R. Hankosky, Karishma Desai, Chanadda Chinthammit, et al.
Diabetes & Metabolism (2025), pp. 101636-101636
Open Access
An overview of obesity‐related complications: The epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes
Matthias Blüher
Diabetes Obesity and Metabolism (2025)
Open Access
Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss
Allison B. Reiss, Shelly Gulkarov, Raymond Lau, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 408-408
Open Access
Development and Validation of a Simple Model to Predict Patient Height
Emily E. Moin, Nicholas J. Seewald, Scott D. Halpern
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Proteomic signatures of type 2 diabetes predict the incidence of coronary heart disease
Yujian Li, Dun Li, Jing Lin, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Cardiovascular effects of anti-obesity medications: the perils and promise
Haoyi Zheng
Cardiology Plus (2025)
Open Access
Real‐world impact of tirzepatide on the risk of progression to type 2 diabetes and metabolic outcomes in people with obesity and pre‐diabetes
Scott A. Coon, Raechel T. White, Dominique Pagnozzi, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Comparing clinical outcomes of adults with obesity receiving tirzepatide versus bariatric metabolic surgery: A multi‐institutional propensity score‐matched study
Jheng‐Yan Wu, S.C Chan, Wan‐Hsuan Hsu, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Duodenal mucosa resurfacing: the endoscopic silver bullet against metabolic disorders?
Amedeo Lonardo, Ashwani K. Singal
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 1
Open Access
Effect of tirzepatide on OSA-related cardiometabolic risk measures in SURMOUNT-OSA
Josef Bednařík, Atul Malhotra, Ronald R. Grunstein, et al.
Research Square (Research Square) (2025)
Closed Access
The Goldilocks for chronic weight management—Balancing quantity with quality of weight loss
Kim Henriksen, Manu V. Chakravarthy, Cecilie Liv Bager, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Bile acids and incretins as modulators of obesity-associated atherosclerosis
Andrijana Kirsch, Juergen Gindlhuber, Diana Zabini, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 11
Open Access
Mémoire adipocytaire de l’obésité et rechute pondérale : la réponse n’est-elle pas la prévention plutôt que les médicaments ?
Serge Halimi
Médecine des Maladies Métaboliques (2025)
Closed Access
Pre-Type 1 Diabetes in Adolescents and Teens: Screening, Nutritional Interventions, Beta-Cell Preservation, and Psychosocial Impacts
Brody Sundheim, Krish Hirani, M Blaschke, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 383-383
Open Access
Page 1 - Next Page

Scroll to top